Methicillin-resistant Staphylococcus aureus, the hard-to-control superbug, wreaks havoc on the surgical patients who contract it and is a financial burden for hospitals, new research shows.
Compared with patients who go home from surgery uninfected, patients with MRSA infections are 35 times more likely to be readmitted to the hospital and seven times more likely to die within three months, according to a study in the December 2009 PLoS ONE. …
The study also found that patients infected with MRSA after surgery spent an additional three weeks in the hospital and cost $60,000 more to care for.
The whole shebang.